Last updated on
The stock has been delisted from the stock exchange on 20 Mar 2025
Check the interactive Achilles Therapeutics Pl-adr Stock chart to analyse performance
Check Achilles Therapeutics Pl-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Name
Holdings %
Syncona Portfolio Ltd.
26.98%
BML Capital Management LLC
9.98%
FCPM III SERVICES BV
5.82%
Redmile Group, LLC
3.91%
Vestal Point Capital LP
3.65%
Ikarian Capital, LLC
3.51%
Buy
70%Buy
20%Hold
10%Sell
Based on 10 Wall street analysts offering stock ratings for Achilles Therapeutics Pl-adr(by analysts ranked 0 to 5 stars)
Achilles Therapeutics Pl-adr share price today is as on at the close of the market. Achilles Therapeutics Pl-adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
Achilles Therapeutics Pl-adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Achilles Therapeutics Pl-adr stock price today i.e. is closed at , lower by 100% versus the 52 week high.
Indian investors can start investing in Achilles Therapeutics Pl-adr (ACHL) shares with as little as ₹88.2013 or $1 (as of September 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Achilles Therapeutics Pl-adr stock (as per the Rupee-Dollar exchange rate as on September 16, 2025).
Learn more about
fractional shares .
Achilles Therapeutics Pl-adr stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
$186.01
-0.65%
$232.81
-1.39%
$30.61
+0.86%
$39.12
+0.03%
$37.12
+1.25%
$183.81
+0.73%
$544.10
-0.02%
$100.18
-1.14%